Transcriptomic Profiling Pre- and Post-Dupilumab Treatment in Atopic Dermatitis Using Minimally Invasive Microneedle Sampling: A Pilot Study

Individual differences in dupilumab treatment response remain an unmet need. This pilot study aimed to explore transcriptomic changes and candidate molecular signals that may reflect disease activity and treatment response by analyzing gene expression changes in patients with atopic dermatitis (AD) using a minimally invasive microneedle-based skin sampling method (MISSM). Lesional and non-lesional skin samples were collected from six patients with moderate to severe AD before and 16 weeks after dupilumab treatment, and only samples exceeding a predefined complementary RNA (cRNA) yield threshold following pico-scale RNA amplification were analyzed by microarray. Transcriptome profiling identified several genes, including immunoglobulin variable-region and T-cell receptor genes, that showed correlation trends with clinical improvement (change in Eczema Area and Severity Index, ΔEASI) and significant changes after treatment in the responder group. Baseline expression of other immune-related genes, such as chemokines and immunoglobulins, differed between responders and non-responders. As these findings were derived from a small, non-independent cohort, they should be regarded as exploratory signals rather than validated biomarkers. We also demonstrated that MISSM is a feasible platform for multi-layered analysis of molecular changes in AD, supporting its potential utility for longitudinal treatment response monitoring and molecular profiling in chronic inflammatory skin disease.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-12
DOI
https://doi.org/10.3390/ijms272210150
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Transcriptomic Profiling Pre- and Post-Dupilumab Treatment in Atopic Dermatitis Using Minimally Invasive Microneedle Sampling: A Pilot Study

Narang Hong, Dohyeon Jeong, Jiyoung Ahn, Seo Hyeong Kim et al.
International Journal of Molecular Sciences
Dermatology and Skin Diseases
article

Transcriptomic Profiling Pre- and Post-Dupilumab Treatment in Atopic Dermatitis Using Minimally Invasive Microneedle Sampling: A Pilot Study

Narang Hong, Dohyeon Jeong, Jiyoung Ahn, Seo Hyeong Kim, Ji Hye Kim, Kwang Hoon Lee, Ho Eun Gwag, Ji Tae Kim
article en

Abstract

Individual differences in dupilumab treatment response remain an unmet need. This pilot study aimed to explore transcriptomic changes and candidate molecular signals that may reflect disease activity and treatment response by analyzing gene expression changes in patients with atopic dermatitis (AD) using a minimally invasive microneedle-based skin sampling method (MISSM). Lesional and non-lesional skin samples were collected from six patients with moderate to severe AD before and 16 weeks after dupilumab treatment, and only samples exceeding a predefined complementary RNA (cRNA) yield threshold following pico-scale RNA amplification were analyzed by microarray. Transcriptome profiling identified several genes, including immunoglobulin variable-region and T-cell receptor genes, that showed correlation trends with clinical improvement (change in Eczema Area and Severity Index, ΔEASI) and significant changes after treatment in the responder group. Baseline expression of other immune-related genes, such as chemokines and immunoglobulins, differed between responders and non-responders. As these findings were derived from a small, non-independent cohort, they should be regarded as exploratory signals rather than validated biomarkers. We also demonstrated that MISSM is a feasible platform for multi-layered analysis of molecular changes in AD, supporting its potential utility for longitudinal treatment response monitoring and molecular profiling in chronic inflammatory skin disease.

International Journal of Molecular SciencesVol. 27(22)
National Medical Center (KR)
Good health and well-being
Dermatology and Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon